Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.
Kidney Int. 2013 Jan;83(1):160-6. doi: 10.1038/ki.2012.327. Epub 2012 Sep 5.
Kidney Int. 2013.
PMID: 22951890